{"name":"Naval Aeromedical Research Unit, Dayton","slug":"naval-aeromedical-research-unit-dayton","ticker":"","exchange":"","domain":"","description":"Naval Aeromedical Research Unit, Dayton is a research facility focused on aeromedical research and development, contributing to the advancement of military and civilian health through innovative solutions and technologies.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Scopolamine Transdermal Patch [Transderm Scop]","genericName":"Scopolamine Transdermal Patch [Transderm Scop]","slug":"scopolamine-transdermal-patch-transderm-scop","indication":"Prevention of motion sickness","status":"phase_3"}]}],"pipeline":[{"name":"Scopolamine Transdermal Patch [Transderm Scop]","genericName":"Scopolamine Transdermal Patch [Transderm Scop]","slug":"scopolamine-transdermal-patch-transderm-scop","phase":"phase_3","mechanism":"Scopolamine acts as a muscarinic acetylcholine receptor antagonist, blocking the action of acetylcholine at muscarinic receptors in the central and peripheral nervous system.","indications":["Prevention of motion sickness","Treatment of postoperative nausea and vomiting"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}